Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-7-10
|
pubmed:abstractText |
Insulin-dependent (Type I) diabetes mellitus is a chronic autoimmune disease. From studies in discordant twins and multiplex families a long prediabetic period has been reported. In a population-based program started in 1983, fifteen individuals at possible risk for future Type I diabetes were followed for up to 74 months. Two individuals (13%) developed Type I diabetes. These probands were characterized by the presence of high-level cytoplasmic islet cell antibodies (ICA), complement-fixing ICA, and an impaired first-phase insulin response after intravenous glucose load. Both were homozygous for a high-risk immunogenetic marker of Type I diabetes, i.e., non-Asp at codon 57 of the HLA-DQ beta chain. In all other subjects studied, the immunogenetic marker that confers "dominant resistance", aspartic acid at codon 57, was found. On the basis of our data we conclude that a combination of assays which determine ICA, first-phase insulin release, and HLA-DQB1 polymorphisms will identify individuals with a high probability of developing Type I diabetes at the population level. Conversely, HLA haplotypes positive for aspartic acid seem to confer resistance to the disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Genetic Markers,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ beta-Chains,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQbeta antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/islet cell antibody
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0023-2173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
146-50
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2041376-Adult,
pubmed-meshheading:2041376-Amino Acid Sequence,
pubmed-meshheading:2041376-Aspartic Acid,
pubmed-meshheading:2041376-Autoantibodies,
pubmed-meshheading:2041376-Diabetes Mellitus, Type 1,
pubmed-meshheading:2041376-Female,
pubmed-meshheading:2041376-Genetic Markers,
pubmed-meshheading:2041376-HLA-DQ Antigens,
pubmed-meshheading:2041376-HLA-DQ beta-Chains,
pubmed-meshheading:2041376-HLA-DR Antigens,
pubmed-meshheading:2041376-Humans,
pubmed-meshheading:2041376-Hyperglycemia,
pubmed-meshheading:2041376-Islets of Langerhans,
pubmed-meshheading:2041376-Male,
pubmed-meshheading:2041376-Polymerase Chain Reaction,
pubmed-meshheading:2041376-Risk Factors,
pubmed-meshheading:2041376-Thyroiditis, Autoimmune
|
pubmed:year |
1991
|
pubmed:articleTitle |
Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus.
|
pubmed:affiliation |
Klinikum der Johann Wolfgang Goethe-Universität, Zentrum der Inneren Medizin, Frankfurt, Main, FRG.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|